The COVID pandemic drew public attention to an issue already well known in health care circles: the challenges hospitals face…
The U.S. Food and Drug Administration could bolster public trust in medicines through greater transparency about its decisions on when…
Congress has a chance in September to try to speed the pace of studies needed to confirm whether drugs sold…
September is a great time for journalists to examine how well U.S. regulators are handling the accelerated approval pathway for…
The cost of naloxone has risen sharply for people lacking insurance, even as laws have made it easier to prescribe…
The Biden administration plans to leverage the federal government’s clout as a major purchaser of health services to try to…
A biotechnology company expects to get a rare second chance to try to win the support of a key federal…
Tomorrow (July 16) is the official launch date for “988,” which converts the existing 10-digit National Suicide Prevention Lifeline to…
Federal officials intend to give hospitals a break in quality scoring due to pandemic strains, by halting reporting of a…
The Department of Health and Human Services (HHS) on Wednesday outlined plans to try to protect patients’ civil rights and…